Results 191 to 200 of about 505,764 (311)
Case Report: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. [PDF]
Jiang C, Sun T, Xu X, Xu W, You K.
europepmc +1 more source
An implantable hydrogel is designed to hold gene transfection agents engineered to turn early recurrent tumor cells into generators of synthetic EVs. These synthetic EVs can express engineered miR‐26a (E‐miR‐26a) for highly sensitive detection and PD‐1 (a PD‐L1‐blocking agent) for therapeutic intervention, thereby enabling early detection and ...
Junli Zhang +7 more
wiley +1 more source
Standardized protocols for blood collection and analysis in elasmobranchs: a practical guide for clinicians and researchers. [PDF]
David H +3 more
europepmc +1 more source
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong +8 more
wiley +1 more source
[Electrophoresis of blood proteins in vascular diseases].
R C, MAYALL +2 more
openaire +1 more source
Eosinophilic granulomatosis with polyangiitis coexisting with multiple myeloma: independent entities or coexistence? A case report. [PDF]
Qin L +8 more
europepmc +1 more source
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi +15 more
wiley +1 more source
ELECTROPHORESIS OF BLOOD PROTEINS OF DOGS WITH MAMMARY TUMOURS
O. Fedets, I. Kurlyak, O. Zayats
openaire +2 more sources
Unmasking Oligosecretory multiple myeloma: a case report highlighting diagnostic pitfalls. [PDF]
Solórzano Flores C +3 more
europepmc +1 more source
Upon inhalation, RM@TNT could persist long‐term in the diseased lungs, while undergoing disintegration to release TNT specifically within the ROS‐rich pathological microenvironments of SA‐ARDS. The released TNT was then precisely delivered to AMs via Tuftsin, where it released Nob intracellularly to activate BMAL1 expression, thus inhibiting AM ...
Yunlong Zhang +23 more
wiley +1 more source

